HN1999000159A - Administracion de agente activo en polvo seco. - Google Patents

Administracion de agente activo en polvo seco.

Info

Publication number
HN1999000159A
HN1999000159A HN1999000159A HN1999000159A HN1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A HN 1999000159 A HN1999000159 A HN 1999000159A
Authority
HN
Honduras
Prior art keywords
active agent
dry powder
administration
depths
lung
Prior art date
Application number
HN1999000159A
Other languages
English (en)
Inventor
Inhale Therapeutic Systems Inc
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of HN1999000159A publication Critical patent/HN1999000159A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE RELACIONA CON LA ADMINISTRACION MEJORADA DE UNA FORMULACION DE AGENTE ACTIVO EN POLVO SECO HACIA LAS PROFUNDIDADES DEL PULMON.
HN1999000159A 1998-09-14 1999-09-13 Administracion de agente activo en polvo seco. HN1999000159A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10016398P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
HN1999000159A true HN1999000159A (es) 1999-11-11

Family

ID=22278404

Family Applications (1)

Application Number Title Priority Date Filing Date
HN1999000159A HN1999000159A (es) 1998-09-14 1999-09-13 Administracion de agente activo en polvo seco.

Country Status (44)

Country Link
EP (1) EP1117442A1 (es)
JP (1) JP2002524535A (es)
KR (1) KR20010075063A (es)
CN (1) CN1317977A (es)
AP (1) AP1374A (es)
AR (1) AR022090A1 (es)
AU (1) AU753014B2 (es)
BG (1) BG105430A (es)
BR (1) BR9913722A (es)
CA (1) CA2343920A1 (es)
CO (1) CO5130023A1 (es)
CZ (1) CZ2001829A3 (es)
DZ (1) DZ2892A1 (es)
EA (1) EA003476B1 (es)
EE (1) EE200100151A (es)
GE (1) GEP20043257B (es)
GT (1) GT199900156A (es)
HK (1) HK1042231A1 (es)
HN (1) HN1999000159A (es)
HR (1) HRP20010189A2 (es)
HU (1) HUP0103837A3 (es)
ID (1) ID28845A (es)
IL (2) IL141562A0 (es)
IS (1) IS5878A (es)
LT (1) LT4897B (es)
LV (1) LV12658B (es)
MA (1) MA25590A1 (es)
MY (1) MY129282A (es)
NO (1) NO20011251L (es)
NZ (1) NZ510168A (es)
OA (1) OA11781A (es)
PA (1) PA8481901A1 (es)
PE (1) PE20001061A1 (es)
PL (1) PL195574B1 (es)
SA (1) SA99200718B1 (es)
SK (1) SK3442001A3 (es)
TN (1) TNSN99173A1 (es)
TR (1) TR200101182T2 (es)
TW (1) TWI226248B (es)
UA (1) UA76085C2 (es)
UY (1) UY25711A1 (es)
WO (1) WO2000015262A1 (es)
YU (1) YU24201A (es)
ZA (1) ZA200101995B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630121B1 (en) 1999-06-09 2003-10-07 The Regents Of The University Of Colorado Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) * 2001-02-15 2002-11-05 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
EG24184A (en) * 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7351844B2 (en) 2002-02-25 2008-04-01 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
CA2491129A1 (en) * 2002-07-03 2004-01-15 Brigham And Women's Hospital, Inc. Central airway administration for systemic delivery of therapeutics
DE60311875T2 (de) * 2002-12-19 2007-08-30 Pharmacia Corp. Nicht-hygroskopische formulierung, die einen hygroskopischen wirkstoff enthält
DE10338403A1 (de) * 2003-08-18 2005-03-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
PT2708225T (pt) * 2004-04-23 2019-05-21 Cydex Pharmaceuticals Inc Formulação de dpi contendo éter sulfoalquílicociclodextrina
EP1853544A4 (en) 2005-02-24 2010-06-16 Diffusion Pharmaceuticals Llc TRANSCAROTENOIDS AND THEIR SYNTHESIS, THEIR PREPARATION AND USES THEREOF
JPWO2006095788A1 (ja) * 2005-03-09 2008-08-14 小野薬品工業株式会社 粒子およびその粒子を含有する製剤
ES2532374T3 (es) 2005-10-26 2015-03-26 Cydex Pharmaceuticals, Inc. Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
US7629331B2 (en) 2005-10-26 2009-12-08 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
WO2008021451A2 (en) * 2006-08-14 2008-02-21 Aktiv-Dry Llc Human-powered dry powder inhaler and dry powder inhaler compositions
KR20090081407A (ko) * 2006-10-25 2009-07-28 다이닛본 스미토모 세이야꾸 가부시끼가이샤 고결 방지 과립상 제제
EP1925295A1 (de) * 2006-11-22 2008-05-28 Boehringer Ingelheim Pharma GmbH & Co. KG Stabile Pulverformulierung enthaltend ein Anticholinergikum
MX2009010988A (es) 2007-04-13 2010-03-15 Diffusion Pharmaceuticals Llc Uso de trans-carotenoides bipolares como un tratamiento previo y en el tratamiento de una enfermedad vascular periferica.
WO2009058399A1 (en) 2007-10-31 2009-05-07 Diffusion Pharmaceuticals Llc A new class of therapeutics that enhance small molecule diffusion
CN105770882A (zh) 2009-05-20 2016-07-20 Aeras全球Tb疫苗基金会 稳定的经喷雾干燥的免疫原性的病毒组合物
CN108464976A (zh) 2009-06-22 2018-08-31 扩散药品有限公司 扩散促进化合物及其单独或与溶栓药一起的应用
CN105287473A (zh) 2010-06-02 2016-02-03 扩散药品有限公司 包含双极性反式类胡萝卜素的组合物及其应用
SG10201607288VA (en) 2012-05-03 2016-10-28 Janssen Sciences Ireland Uc Polyinosinic-polycytidylic acid (poly (i:c)) formulations for the treatment of upper respiratory tract infections
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
WO2015042352A1 (en) * 2013-09-20 2015-03-26 Virginia Commonwealth University Delivery of particles using hygroscopic excipients
DK3212212T3 (da) 2014-10-31 2020-12-21 Univ Monash Pulverformulering
EP3432929A4 (en) 2016-03-24 2019-11-27 Diffusion Pharmaceuticals LLC USE OF BIPOLAR TRANSCAROTINOIDS WITH CHEMOTHERAPY AND RADIOTHERAPY FOR THE TREATMENT OF CANCER
US20220378727A1 (en) * 2021-05-14 2022-12-01 The University Of Hong Kong Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
AU659328B2 (en) * 1992-06-12 1995-05-11 Teijin Limited Ultrafine powder for inhalation and production thereof
US6524557B1 (en) * 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
EP0954282B1 (en) * 1997-01-16 2005-01-19 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

Also Published As

Publication number Publication date
UA76085C2 (en) 2006-07-17
IL141562A0 (en) 2002-03-10
NZ510168A (en) 2003-09-26
AU6039799A (en) 2000-04-03
MA25590A1 (fr) 2002-12-31
WO2000015262A1 (en) 2000-03-23
NO20011251D0 (no) 2001-03-13
AU753014B2 (en) 2002-10-03
HK1042231A1 (zh) 2002-08-09
LV12658A (lv) 2001-05-20
JP2002524535A (ja) 2002-08-06
UY25711A1 (es) 1999-11-17
LT4897B (lt) 2002-02-25
IS5878A (is) 2001-03-05
CO5130023A1 (es) 2002-02-27
BG105430A (en) 2001-12-29
CN1317977A (zh) 2001-10-17
LT2001021A (en) 2001-11-26
ZA200101995B (en) 2002-03-11
PL346768A1 (en) 2002-02-25
ID28845A (id) 2001-07-05
HRP20010189A2 (en) 2005-04-30
PA8481901A1 (es) 2002-04-25
PE20001061A1 (es) 2000-10-08
SK3442001A3 (en) 2001-11-06
MY129282A (en) 2007-03-30
TWI226248B (en) 2005-01-11
HUP0103837A3 (en) 2002-11-28
TNSN99173A1 (fr) 2005-11-10
GEP20043257B (en) 2004-06-25
PL195574B1 (pl) 2007-10-31
AP2001002093A0 (en) 2001-03-31
TR200101182T2 (tr) 2001-09-21
GT199900156A (es) 2001-03-07
EE200100151A (et) 2002-06-17
YU24201A (sh) 2003-08-29
NO20011251L (no) 2001-04-17
CZ2001829A3 (cs) 2001-09-12
EP1117442A1 (en) 2001-07-25
CA2343920A1 (en) 2000-03-23
BR9913722A (pt) 2001-05-29
KR20010075063A (ko) 2001-08-09
DZ2892A1 (fr) 2003-12-15
EA003476B1 (ru) 2003-06-26
EA200100300A1 (ru) 2001-10-22
AP1374A (en) 2005-02-28
SA99200718B1 (ar) 2006-11-04
HUP0103837A2 (hu) 2002-05-29
AR022090A1 (es) 2002-09-04
OA11781A (en) 2005-07-26
LV12658B (lv) 2001-09-20
IL141562A (en) 2007-07-24

Similar Documents

Publication Publication Date Title
HN1999000159A (es) Administracion de agente activo en polvo seco.
NO20005019D0 (no) Strukturer og fremgangsmÕter for dannelse av hulrom i indre kroppsomrÕder
DK1582204T3 (da) Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer
AR025071A1 (es) Aditivo para mejorar la resistencia al agua de formulaciones cosmeticas o dermatologicas
ES2171971T3 (es) Producto limpiador y de tratamiento con almidon.
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
ES2154503T3 (es) Composicion cosmetica o dermatologica.
DE602005024601D1 (de) Zweikomponenten-zahnbleichzusammensetzungen
MY115628A (en) Cosmetic composition
AR020760A1 (es) DISPOSITIVO PARA CONTROLAR LA ADMINISTRACIoN DE UN AGENTE ACTIVO EN AEROSOL EN LOS PULMONES DE UN PACIENTE HUMANO
ES2187749T3 (es) Composicion agroquimica envasada.
MX9304742A (es) Mejoras en solvente limpiador no flamable de olor suave.
ATE385760T1 (de) Remineralisierende dental-klebefolie
EA200200151A1 (ru) Сухая порошкообразная композиция
ATE321534T1 (de) Verbesserte liposomale formulierung
ATE301986T1 (de) Kosmetische stiftzubereitung
BR9910024A (pt) Agente contra resfriado
AR027504A1 (es) Composiciones para decolorar y tenir el cabello
BR9917389B1 (pt) formulaÇÕes tàpicas compreendendo agentes de penetraÇço na pele e o uso das mesmas.
JPS567711A (en) Cosmetic
ES2095200T1 (es) Agente para la transformacion permanente del cabello asi como esteres de cisteina reductores de la queratina del cabello.
AR044697A1 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
CO5640085A2 (es) Formulaciones farmaceuticas que comprenden amoxicilina y clavulanato
DE60137569D1 (de) Pulegon enthaltende kosmetische hautpflegezusammensetzungen
ITFO20020011A1 (it) Strumento di cannula vaginale atto ad eseguire irrigazioni vaginali con successiva somministrazione in vagina di principi attivi in formulaz